Daily Technical Analysis Weekly Analysis Monthly Analysis Renko chart MACD chart Bollinger Bands chart Stochastics charts Force Index charts

(GLAXO) Glaxosmithkline Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Glaxosmithkline Pharmaceuticals | (GLAXO) share price targets

Complete technical analysis of Glaxosmithkline Pharmaceuticals (GLAXO) by charts plus indicators, forecast predictions and share price targets for Glaxosmithkline Pharmaceuticals (GLAXO)

Glaxosmithkline Pharmaceuticals trades in NSE in Pharmaceuticals sector.

Showing technical analysis as on 2024-03-19 View latest technical analysis

10 day averaged volume of Glaxosmithkline Pharmaceuticals is 181166

Date	Daily Closing Price	Open	High	Low	Volume
19 Tue Mar 2024	1952.55	1976.00	2004.85	1932.05	1.131 times
18 Mon Mar 2024	1972.25	1905.60	1995.95	1905.60	1.278 times
15 Fri Mar 2024	1926.55	1970.90	1983.00	1900.00	1.144 times
14 Thu Mar 2024	1969.05	1926.95	1988.00	1913.00	0.695 times
13 Wed Mar 2024	1926.30	2001.00	2015.20	1898.00	1.227 times
12 Tue Mar 2024	2001.25	2011.95	2037.85	1976.50	0.915 times
11 Mon Mar 2024	2009.40	2049.95	2102.00	1991.50	1.456 times
07 Thu Mar 2024	2049.95	2075.00	2080.55	2026.85	0.818 times
06 Wed Mar 2024	2072.40	2120.05	2134.75	2051.30	1.33 times
05 Tue Mar 2024	2130.50	2150.35	2158.60	2103.20	0.457 times

My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 1988.5, but if it comes above 1988.5, then a intra day buy could be more profitable.
If you take a sell trade below 1988.5, then use 1988.5 as stoploss and 1871.7 as target. However if you take a buy trade in stock , then use 1988.5 as stoploss and 2085.83 as target.

Share price targets for Glaxosmithkline Pharmaceuticals (GLAXO)

Target Type	Value
Downside Target	1385.05
Downside Target	1661.35
Downside Target	1727.00
Downside Target	1898.00
Upside Target	1959.00
Upside Target	2004.85
Upside Target	2091.05
Upside Target	2191.00
Upside Target	2268.00
Upside Target	2318.25
Upside Target	2374.80
Upside Target	2524.00

Intraday share price targets for Glaxosmithkline Pharmaceuticals (GLAXO)

Target Type	Value
Downside Intraday Target	1903.82
Downside Intraday Target	1855.08
Upside Intraday Target	2003.07
Upside Intraday Target	2053.58
Upside Intraday Target	1954.33

Weekly technical analysis of Glaxosmithkline Pharmaceuticals (GLAXO)

Date	Weekly Closing Price	Open	High	Low	Volume
19 Tue Mar 2024	1952.55	1905.60	2004.85	1905.60	0.443 times
15 Fri Mar 2024	1926.55	2049.95	2102.00	1898.00	1.655 times
07 Thu Mar 2024	2049.95	2191.00	2191.00	2026.85	0.642 times
02 Sat Mar 2024	2173.15	2170.85	2268.00	2117.05	1.57 times
23 Fri Feb 2024	2170.80	2318.25	2318.25	2149.50	0.505 times

Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.

Monthly technical analysis of Glaxosmithkline Pharmaceuticals (GLAXO)

Date	Monthly Closing Price	Open	High	Low	Volume
19 Tue Mar 2024	1952.55	2170.00	2191.00	1898.00	0.552 times
29 Thu Feb 2024	2173.65	2250.00	2524.00	2091.05	0.481 times
31 Wed Jan 2024	2249.90	1905.90	2374.80	1904.45	1.82 times
29 Fri Dec 2023	1898.15	1670.00	1959.00	1661.35	1.022 times

Scroll below to view daily charts

Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.

Indicators analysis of Glaxosmithkline Pharmaceuticals (GLAXO)

Price action analysis of Glaxosmithkline Pharmaceuticals ( (GLAXO) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.

Price action analysis of Glaxosmithkline Pharmaceuticals ( (GLAXO) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

Price action analysis of Glaxosmithkline Pharmaceuticals ( (GLAXO) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

Price action analysis of Glaxosmithkline Pharmaceuticals ( (GLAXO) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for Glaxosmithkline Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is losing momentum.

MACD generated a SELL signal for Glaxosmithkline Pharmaceuticals in short term and the sell signal is strong.

Glaxosmithkline Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a buy signal for Glaxosmithkline Pharmaceuticals in short term but BUY signal is weak.

RSI is generating a BUY signal in short term and the buying is gaining momentum.

MRSI is in negative zone. This is the SELL zone

Although the stock is in the SELL zone, but selling might be slowing down

Stock of Glaxosmithkline Pharmaceuticals is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 1992.96 and Glaxosmithkline Pharmaceuticals (GLAXO) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Glaxosmithkline Pharmaceuticals (GLAXO) stock. Volume based technical analysis of Glaxosmithkline Pharmaceuticals (GLAXO) stock is negative.

Glaxosmithkline Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.